Powered by

Hepatocellular Carcinoma Drugs Market 2020-2024 | Forecasting Strategy to Undergo a Paradigm Shift From Crisis to New Normal During COVID-19 Pandemic | Technavio

Nov 24, 2020 - Business Wire

The hepatocellular carcinoma drugs market is poised to grow by USD 85.10 million during 2020-2024, progressing at a CAGR of over 3% during the forecast period. Technavio's report estimates the outbreak of COVID-19 to have a neutral impact on the market. The market demand is expected to remain unaffected and continue to increase due to the rising prevalence of diabetes. Besides, many pharmaceutical giants and several governments across the world are making huge investments in R&D activities to de...